Guardant Health Showcases Shield Test’s Accuracy Across 10 Cancers

Guardant Health Unveils Compelling Data on Shield Multi-Cancer Detection Test at AACR 2025, Showcasing High Specificity and Sensitivity Across Ten Tumor Types Guardant Health, Inc. (Nasdaq: GH), a prominent leader in precision oncology, has released new clinical data demonstrating the…










